Growth Metrics

Exact Sciences (EXAS) Cash from Investing Activities (2016 - 2025)

Exact Sciences has reported Cash from Investing Activities over the past 16 years, most recently at $91.1 million for Q4 2025.

  • Quarterly Cash from Investing Activities rose 317.61% to $91.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195.1 million through Dec 2025, up 144.13% year-over-year, with the annual reading at $195.1 million for FY2025, 144.13% up from the prior year.
  • Cash from Investing Activities was $91.1 million for Q4 2025 at Exact Sciences, up from -$86.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $224.9 million in Q2 2025 and troughed at -$793.8 million in Q2 2021.
  • The 5-year median for Cash from Investing Activities is -$38.2 million (2024), against an average of -$60.3 million.
  • Year-over-year, Cash from Investing Activities crashed 12341.49% in 2021 and then surged 317.61% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $78.4 million in 2021, then crashed by 174.15% to -$58.2 million in 2022, then fell by 14.8% to -$66.8 million in 2023, then surged by 37.29% to -$41.9 million in 2024, then skyrocketed by 317.61% to $91.1 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cash from Investing Activities are $91.1 million (Q4 2025), -$86.5 million (Q3 2025), and $224.9 million (Q2 2025).